IDEXX Laboratories, Inc. (LON: 0J8P)
Market Cap | 26.85B |
Revenue (ttm) | 2.87B |
Net Income (ttm) | 646.30M |
Shares Out | n/a |
EPS (ttm) | 7.73 |
PE Ratio | 41.55 |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 147 |
Open | 406.78 |
Previous Close | 412.59 |
Day's Range | 405.25 - 417.29 |
52-Week Range | 373.77 - 583.30 |
Beta | n/a |
Analysts | n/a |
Price Target | n/a |
Earnings Date | Feb 3, 2025 |
About IDEXX Laboratories
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnos... [Read more]
Financial Performance
In 2023, IDEXX Laboratories's revenue was $3.66 billion, an increase of 8.72% compared to the previous year's $3.37 billion. Earnings were $845.04 million, an increase of 24.44%.
Financial numbers in USD Financial StatementsNews
SR Inc Announces 2024 SBER Awards: Top Honors Go to Synopsys, Nell Triplett of Juniper Networks, and IDEXX
Sustainability Roundtable Inc. announced Synopsys, IDEXX, and Juniper Networks as winners of the 2024 SBER Awards for standout leadership in sustainability
Why Investors Are Eyeing IDEXX Laboratories Inc (IDXX): The Key Drivers of Market ...
Why Investors Are Eyeing IDEXX Laboratories Inc (IDXX): The Key Drivers of Market Outperformance and Growth Potential
IDEXX Laboratories (IDXX) Expands Share Repurchase Program
IDEXX Laboratories (IDXX) Expands Share Repurchase Program
IDEXX Laboratories Inc (IDXX) Expands Share Repurchase Program
IDEXX Laboratories Inc (IDXX) Expands Share Repurchase Program
IDEXX Laboratories reloads buyback firepower
IDEXX Laboratories Announces Increase in Share Repurchase Program Authorization
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that the Company's Board of Directors authorized an increase i...
Insider Sell: Sophie Vandebroek Sells Shares of IDEXX Laboratories Inc (IDXX)
Insider Sell: Sophie Vandebroek Sells Shares of IDEXX Laboratories Inc (IDXX)
Executive reshuffles: MFC, LYB, IDXX and TEX
Recent management changes in various companies include retirements and new appointments in key executive roles, impacting their growth prospects.
IDEXX Laboratories (IDXX) Announces CFO Transition
IDEXX Laboratories (IDXX) Announces CFO Transition
IDEXX Announces CFO Transition
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Brian McKeon has decided to retire from IDEXX effective J...
ACVIM and IDEXX Partner to Provide Free Educational Offerings for ACVIM Residents
DENVER--(BUSINESS WIRE)--The American College of Veterinary Internal Medicine (ACVIM) is excited to announce a new endorsement partnership with IDEXX Laboratories, Inc., of complimentary resident-focu...
IDEXX Laboratories Q3: Weak End-Market Demand Continues
I reiterate a 'Sell' rating on IDEXX due to weak U.S. clinical visits and demand, with a one-year price target of $400 per share. IDEXX's Q3 results showed a 2.1% decline in same-store clinical visits...
IDEXX Laboratories, Inc. (IDXX) Q3 2024 Earnings Call Transcript
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q3 2024 Earnings Conference Call October 31, 2024 8:30 AM ET Company Participants Brian McKeon - CFO Jay Mazelsky - President and CEO Conference Call Participan...
CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results
WESTBROOK, Maine--(BUSINESS WIRE)--In the 2024 Growth and Financial Performance Outlook section, second paragraph, second sentence should read: At midpoint, projected full year comparable operating pr...
Idexx Laboratories Adjusts Guidance As Q3 Revenue Growth Slows, Analyst Notes Fewer Veterinary Visits, Looks Towards Long-Term Growth
Idexx Laboratories Inc IDXX reported third-quarter adjusted EPS of $2.79, up 12% year-over-year, beating the consensus of $2.68.
IDEXX laboratories cuts annual revenue forecast for third time as pet clinic visits slow
IDEXX Laboratories trimmed its annual revenue forecast for the third time on Thursday, as the animal health diagnostic equipment maker sees fewer visits to veterinary clinics from pet owners.
IDEXX Laboratories Announces Third Quarter Results
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced third quarter results. Third Quarter Results The Company repor...
IDEXX Laboratories to Release 2024 Third Quarter Financial Results
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 third quarter results for Thursday, Octo...
IDEXX Laboratories to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Jay Mazelsky, President and Chief Executive Officer, and ...
IDEXX Laboratories Q2: Headwinds From Low U.S. Clinical Visits
IDEXX reported lower full-year organic revenue growth due to reduced U.S. clinical visits. Weak consumer sentiment and ongoing staffing challenges may continue to impact clinical visits in the near fu...
Animal Health Firm Idexx's Robust Business Model Bolsters Position Despite Slower Growth, Says Analyst
Tuesday, Idexx Laboratories Inc IDXX reported second-quarter adjusted EPS of $3.02, up 15% year-over-year, beating the consensus of $2.88.
IDEXX Laboratories, Inc. (IDXX) Q2 2024 Earnings Call Transcript
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q2 2024 Earnings Conference Call August 6, 2024 8:30 AM ET Company Participants Brian McKeon - CFO Jay Mazelsky - President and CEO Conference Call Participants...
IDEXX Laboratories Announces Second Quarter Results
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced second quarter results. Second Quarter Results The Company rep...
The Final Peak Week Of The Q2 Season Begins Amid Souring Economic Data
This marks the last peak week of the Q2 earnings season with 3,908 companies expected to report. Earnings have come in better-than-expected, but tend to be overshadowed by economic data. Outlier earni...
IDEXX Laboratories Announces Time Change for 2024 Second Quarter Financial Results Conference Call
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will now host its 2024 second quarter conference call and webcast at 9:00 am E...